What If Preventing Cancer Is as Easy as Being Vaccinated?

Biedrzycki, Barbara A.
August 2006
ONS News;Aug2006, Vol. 21 Issue 8, p9
Academic Journal
The article reports on the development of a human papillomavirus (HPV) vaccine intended for the prevention of cervical cancer among men and women worldwide. HPV has been sought to be the most common sexually transmitted disease with 20 million men and women have been infected. With the approval of the U.S. Food and Drug Administration, the Gardasil vaccine from Merck & Co. Inc. has been recommended for medication considering its efficacy, its safety and its cost effectiveness.


Related Articles

  • HPV and Cervical Cancer. Leaver, Dennis; Labonte, Geri // Radiation Therapist;Spring2010, Vol. 19 Issue 1, p27 

    Human papillomaviruses (HPVs) are estimated to cause a half million cases of cervical cancer worldwide each year. This article reviews the connection between HPVs and cervical cancer, discusses the HPV vaccine and provides an overview of cervical cancer symptoms, staging and treatment. Case...

  • Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Stanley, M. // British Journal of Cancer;5/7/2007, Vol. 96 Issue 9, p1320 

    Virtually all cases of cervical cancer and its precursor intra-epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs), suggesting that prevention of HPV infection by prophylactic vaccination would be a highly effective anticancer...

  • HPV jab is beneficial even after Ca treatment.  // Pulse;4/4/2012, Vol. 72 Issue 12, p9 

    The article focuses on the benefits of human papilloma virus (HPV) vaccination among women even after cervical cancer treatment, according to a research led by doctor Elmar Joura.

  • Share the Word during National Immunization Month: HPV Vaccine Saves Lives. Culwell, Kelly // La Prensa San Diego;8/8/2014, Vol. 38 Issue 32, p4 

    The article offers the author's view on the importance of undergoing routine vaccination of human papilloma virus (HPV) vaccine to prevent HPV and cervical cancer.

  • Broad-acting HPV vaccines explored to fight cancer. Dorans, Kirsten // Nature Medicine;Apr2009, Vol. 15 Issue 4, p351 

    The article focuses on targeting L2 protein found within the human papillovirus (HPV) for possible development of vaccines that can fight HVP strains that causes cancer. It cites that current marketed HPV vaccines that target protein known as L1 can only neutralize 70% of cervical cancer. Thus,...

  • CERVARIX.  // Monthly Prescribing Reference;Dec2009, Vol. 25 Issue 12, pA10 

    The article offers information on Cervarix vaccine from GlaxoSmithKline. Cervarix has an active ingredient of bivalent human papillomavirus (HPV) vaccine types 16 and 18 vaccine. The drug is used to prevent cervical cancer and cervical intraepithelial neoplasia (CIN) grade 1 in females 10-25...

  • Quadrivalent HPV vaccine prevented cervical neoplasia caused by HPV-16 and HPV-18.  // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p49 

    The article discusses the effectiveness of quadrivalent vaccines against human papillomavirus (HPV) in healthy young women. It is stated that a quadrivalent vaccine against HPV types 6, 11, 16, and 18 was effective in preventing cervical neoplasia caused by HPV-16 or HPV-18 in healthy young...

  • Aceptabilidad y conocimientos sobre la vacunación contra el virus del papiloma humano (VPH) en médicos ginecólogos de la Argentina. Mazzadi, Alejandro; Paolino, Melisa; Arrossi, Silvina // Salud Pública de México;sep/oct2012, Vol. 54 Issue 5, p515 

    Objective. To evaluate HPV vaccine acceptability and prescription; knowledge about HPV vaccine; and knowledge about HPV infection and cervical cancer among Argentinean gynecologists. Materials and methods. Between November 2009 and March 2010 we carried out an internet survey of 686...

  • Reinventing and Contesting Identities in Constitutive Discourses: Between Diaspora and Its Others. Drzewiecka, Jolanta A. // Communication Quarterly;Winter2002, Vol. 50 Issue 1, p1 

    This paper explores how diasporic identities are reinvented through constitutive rhetoric to legitimate certain forms of collective power and action. Diasporic collectivities are constituted in relationship to nation-state systems as well as other groups with whom they share histories and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics